This isn’t the blog that I planned to write this week, but I’m so preoccupied with the outcome of the U.S. election, I’m finding it hard to focus on anything else right now. So, let’s look at the implications of a Trump presidency on science. An article in Nature quotes Michael Lubell, director of public…Read more
A key driver for advancements in regenerative medicine is partnerships. In recognition of this, every year CCRM hosts a networking reception that brings together our partners for an evening of discussion and knowledge sharing. This year’s industry networking reception was focused on the theme of increasing partnerships between industry and academia. I had the privilege…Read more
Elizabeth (Liz) Csaszar is a development manager for the BridGE team at CCRM. Her areas of interest are cell manufacturing, clinical translation of cell based therapies, and blood cell technologies. Liz obtained her PhD at the University of Toronto, focusing on the strategies to expand and self-renew hematopoietic stem cells in vitro. Liz is interested in…Read more
Lots of great sessions today, plus a trainee poster session and pub night.
The feature session of the fifth Till & McCulloch Meetings shone a light on two fantastic researchers, Huijuan Yang and Molly Shoichet, both of whom received awards for their outstanding work. Huijuan Yang, a PhD student in the Nagy lab at the Lunenfeld-Tanenbaum Research Institute at Mount Sinai hospital in Toronto, received the inaugural Drew…Read more
This year’s Till & McCulloch Meetings (TMM2016) began with a diverse set of topics organized into three different plenary sessions. The first session, on regulatory networks in stem cells, began with Sara-Jane Dunn from Microsoft Research who introduced us to “The Reasoning Engine for Interaction Networks, RE:IN,” a computational tool that can synthesize and analyze…Read more